Abstract: Open Access Original Article DOI: 10.7759/cureus.24382 Characteristics and Obstetric Outcomes in Women With Autoimmune Rheumatic Disease During the COVID-19 Pandemic in Qatar Review began 04/11/2022 Review ended 04/21/2022 Eman Satti 1 , Monika Ostensen 2 , soha darrgham 3 , Nawal Hadwan 4 , Hadeel Ashour 4 , Samar AL Emadi 4 Published 04/22/2022 © Copyright 2022 Satti et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., 1. Intenal Medicine, Rheumatology Section, Hamad Medical Corporation, Doha, QAT 2. Department of Rheumatology, Sorlandet Hospital, Kristiansand, NOR 3. Biostatistics, Epidemiology, and Biomathematics Research Core, Weill Cornell Medicine, Doha, QAT 4. Internal Medicine, Rheumatology Section, Hamad Medical Corporation, Doha, QAT which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Corresponding author: Samar AL Emadi, salemadi@hamad.qa Abstract Objective: Pregnant women with autoimmune rheumatic diseases are considered to have a high risk of obstetric complications with the emergence of the Coronavirus disease (COVID-19) pandemic. Therefore, we aimed to assess the impact of COVID-19 on this high-risk group. Methods: This cross-sectional cohort study (March to December 2020) was conducted at the largest tertiary center in Qatar (Hamad Medical Corporation). Eighty consecutive patients following up at the center during pregnancy were surveyed through telephonic interviews. Data on COVID-19 and pregnancy outcomes were extracted from electronic hospital records. Results: Eighty pregnant women with autoimmune rheumatic diseases were included. Among them, 17 (21.3%) (95% confidence interval [CI]: 12.9-31.8%) were diagnosed with COVID-19, five were hospitalized, and only one required intensive care unit admission. The proportion of adverse obstetric outcomes in the cohort was 29.5% (n = 23; 95% CI: 19.7-40.9%). Prematurity (n = 14; 19.4%) and caesarean section (n = 30; 41.1%) were the most prevalent adverse events. There was no statistical difference in adverse pregnancy outcomes between women with and without COVID-19. Conclusion: COVID-19 did not affect pregnancy outcomes in women with autoimmune rheumatic diseases. Categories: Obstetrics/Gynecology, Infectious Disease, Rheumatology Keywords: autoimmune rheumatic diseases, caesarean, covid-19, prematurity, pregnancy